NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.6251
Delayed Data
As of Apr 24
 -0.0049 / -0.78%
Today’s Change
0.42
Today|||52-Week Range
1.30
-0.78%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close0.63
Today’s open0.65
Day’s range0.62 - 0.66
Volume209,157
Average volume (3 months)328,752
Market cap$39.1M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+26.19%
Earnings growth (this year)+41.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-80.33%
P/E ratioNM
Price/Sales29.66
Price/Book17.61

Competitors

 Today’s
change
Today’s
% change
ALXAAlexza Pharmaceutica...-0.06-3.00%
ACURAcura Pharmaceutical...-0.01-1.29%
PTNPalatin Technologies...-0.01-0.98%
RGDORegado Biosciences I...+0.13+10.08%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$684.0K
Annual profit (last year)-$15.2M
Net profit margin-1,441.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers